[Avelox efficacy in the treatment of acute purulent rhinosinusitis].
OBJECTIVE
To compare efficacy of avelox systemic antibiotic therapy with and without maxillary puncture in acute purulent rhinosinusitis (ARS).


METHODS
A total of 40 ARS patients were divided into two groups: puncture was not made in 20 patients of the study group and was made in 20 patients of the control group. Subjective assessment of rhinosinusitis symptoms was made by visual scale Kennedy-Lund, objective assessment was made by x-ray or CT findings.


RESULTS
A clinical response was observed in all 40 patients. Complications or side effects associated with avelox administration were not registered. Regress of rhinosinusitis symptoms did not significantly differ between the controls and test patients. The roentgenographic picture did not differ significantly, CT showed that the response came faster without puncture.


CONCLUSIONS
Systemic antibiotic therapy of uncomplicated purulent rhinosinusitis with avelox is not inferior by efficacy to the standard puncture treatment.
Ivanchenko
O A
OA
Chuchueva
N G
NG
Lopatin
A S
AS
D000208:Acute Disease; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents; D001372:Aza Compounds / Q000627:therapeutic use*; D005260:Female; D024841:Fluoroquinolones; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D015523:Maxillary Sinusitis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000077266:Moxifloxacin; D011804:Quinolines / Q000627:therapeutic use*; D012220:Rhinitis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D013492:Suppuration; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin